Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
06/2002
06/26/2002EP1216240A1 Amide compounds
06/26/2002EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
06/26/2002EP0894084B1 Cinnamic acid derivatives and their use as integrin antagonists
06/26/2002CN1086701C Chloropyridylcarbonyl derivative
06/25/2002US6410802 Etherification in presence of base
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410749 Process for the preparation of optically active amino alcohols
06/25/2002US6410744 Carbonyldiimidazoles, their ester derivatives and method for their production
06/25/2002US6410743 (1s,2s)-2-(2-(n-((3-benzoimidazol-2-yl)propyl)-n-methylamino)ethyl)-6 -fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl cyclopropanecarboxylate, for example; treating vascular disease such as gangrene, retinopathy, nephropathy
06/25/2002US6410600 Azine used as fungicides
06/25/2002US6410580 Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
06/25/2002US6410562 Hypoglycemic imidazoline compounds
06/25/2002US6410542 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
06/25/2002US6410539 Imidazole derivatives and their use as farnesyl protein transferase inhibitors
06/25/2002US6410538 Benzamidine derivatives
06/25/2002US6409812 AZO compounds and process for producing the same
06/21/2002WO2001047894A1 Substituted benzoylcyclohexane diones for use as herbicides
06/21/2002CA2406962A1 Substituted benzoylcyclohexane diones for use as herbicides
06/20/2002WO2002048973A2 A remote control account authorization system
06/20/2002WO2002048157A2 Imidazolidinones and their related derivatives as hepatitis c virus ns3 protease inhibitors
06/20/2002WO2002048124A2 Piperazine derivatives
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002048091A1 Method of introducing amino group and method of synthesizing amino acid compound
06/20/2002WO2002048074A1 Method for producing molecular compound
06/20/2002WO2002048072A2 Organic reactions with co generating materials
06/20/2002WO2002047762A1 Serine protease inhibitors
06/20/2002WO2002020495A3 Inhibitors of glycogen synthase kinase 3
06/20/2002WO2002012243A3 SYNTHESIS OF (R)-3-(4-BROMOBENZYL)-1-(3,5-DICHLOROPHENYL)-5-IODO-3-METHYL-1-H-IMIDAZO[1,2-a]IMIDAZOL-2-ONE
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002US20020077483 Preparing a azole compound on a solid support resin, cleaving the compound from the solid support resin by nucleophilic substitution to further substituting by alkylation reaction
06/20/2002US20020077344 For therapy and prophylaxis of high blood pressure, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, cardiac infarct, vascular restenosis after angioplasty, cardiomyopathies, endothelial dysfunction
06/20/2002US20020077343 H2 receptor antagonist compounds in combination with nitric oxide donors, compostions and methods of use
06/20/2002US20020077338 HIV protease inhibitors
06/20/2002US20020077321 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis
06/20/2002US20020077316 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; Alzheimer's Disease; Syndrome X; peroxisome proliferator activated receptor-associated disorder
06/20/2002DE10063008A1 Carbonsäureamidderivate Carboxamide
06/20/2002CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/19/2002EP1215206A1 Processes for the preparation of 4(5)-amino-5(4)-carboxamidoimidazoles and intermediates thereof
06/19/2002EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation
06/19/2002EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
06/19/2002CN1354740A Pharmaceutical compounds
06/19/2002CN1354175A Preparation method of carbonyl alpha-substitution nitrogenous compound
06/19/2002CN1354173A Method for resolving D-biotin intermediate racemic semi-ester
06/19/2002CN1354172A Method for removing nitrous acid gas
06/18/2002US6407258 Method for producing S-alkyl(aryl)-substituted imidazol derivatives
06/18/2002US6407257 Derivatives of erythromycin, their preparation process and their use as medicaments
06/18/2002US6407233 Halogen pyrimidines and its use thereof as parasite abatement means
06/18/2002US6407132 Substituted imidazole derivatives and their use as histamine H3 receptor ligands
06/18/2002US6407129 Azole compounds, their production and their use
06/18/2002CA2029657C Compositions and their use in lowering intraocular pressure
06/13/2002WO2002046176A1 Ppar (peroxisome proliferator activated receptor) activators
06/13/2002WO2002046167A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/13/2002WO2002046166A1 Phenylethenyl or phenylethinyl derivatives as glutamate receptor antagonists
06/13/2002WO2002008199A3 Efficient ligand-mediated ullmann coupling of anilines and azoles
06/13/2002US20020073416 Remote control account authorization system
06/13/2002US20020072615 Useful as intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated disease
06/13/2002US20020072610 Useful as an intermediate in the preparation of certain small molecules that are useful in therapy or prophylaxis of inflammatory and immune cell-mediated diseases
06/13/2002US20020072529 For therapy and prophylaxis of cerebral apoplexy and craniocerebral trauma
06/13/2002US20020072519 Useful as psychotherapeutic agents
06/13/2002US20020072507 Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono--and di-amino acid salts, and mono-and di-amino acid ester salts
06/13/2002US20020072081 Geranylgeranyl transferase inhibitor screening assay
06/13/2002CA2435467A1 Benzyl (idene)-lactams and their use as 5ht1-receptor ligands
06/12/2002EP1213282A1 Substituted imidazolium salts and their use for the inhibition of protein ageing.
06/12/2002EP1212269A1 Methods for preparing n- (aliphatic or aromatic)carbonyl)]-2-aminoacetamide compounds and for cyclizing such compounds
06/12/2002EP1068192B1 Novel crystalline complexes of baccatin iii with imidazole, 2-methylimidazole or isopropanol
06/12/2002EP1028947B1 H3 receptor ligands of the phenyl-alkyl-imidazoles type
06/12/2002EP0984778B1 Neuropeptide-y ligands
06/12/2002EP0877739B1 Azole compounds endowed with antimycotic activity for human and veterinary use
06/12/2002CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds
06/12/2002CN1353684A Ether compounds, compositions, and uses thereof
06/12/2002CN1353606A IL-8 receptor antagonists
06/12/2002CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof
06/11/2002US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors
06/11/2002US6403806 Synthesis of histamine dihydrochloride
06/11/2002US6403805 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves
06/11/2002US6403644 For prevention and/or treatment of diseases induced by overexpression and excess activity of matrix metalloproteinase; for example, rheumatoid, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis
06/11/2002US6403632 Cyclic amide derivative
06/11/2002US6403592 Serotonin reuptake inhibitors
06/11/2002US6403577 Hexamethyleneiminyl tachykinin receptor antagonists
06/11/2002US6403112 Ectoin and ectoin derivatives as moisturizers in cosmetics
06/06/2002WO2002044141A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/06/2002WO2002044120A1 Compounds active at the glucocorticoid receptor iii
06/06/2002WO2002020474A3 Resorcinol derivatives
06/06/2002WO2002007683B1 Antimicotic nail varnish composition
06/06/2002WO2001087849A3 Modulators of tnf- alpha signaling
06/06/2002US20020068830 Such as 1-((1-(3-(cyclopentyloxy)-4-methoxyphenyl) cyclopropyl)methyl)-1,3-dihydro-2H-imidazol-2-one for allergies, atopic and inflammatory diseases wherein activity of phosphodiesterase is altered
06/06/2002US20020068729 Quaternary salts of substituted imidazoles, oxazoles and thiazoles
06/06/2002US20020068701 Positively charged non-natural amino acids, methods of making thereof, and use thereof in peptides
06/06/2002CA2422729A1 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/05/2002EP1211245A1 Agents for controlling animal diseases caused by parasites
06/05/2002EP1211244A2 4,5-substitued imidazolyl compounds for the treatment of inflammation
06/05/2002EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments
06/05/2002EP1210334A1 Process of making imidazolidine-2-one derivatives
06/05/2002CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same
06/05/2002CN1352554A IL-8 receptor antagaonists
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives
06/04/2002US6399620 Cycloalkyl derivatives as inhibitors of bone resporption and vitronectin receptor antagonists
06/04/2002CA2257016C Imidazolidin-4-one derivatives useful as anticancer agents
05/2002
05/30/2002WO2002042414A2 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues